{"count": 5, "results": [{"_id": "34604353", "pmid": 34604353, "pmcid": "PMC8484763", "title": "Epicardial Fat Expansion in Diabetic and Obese Patients With Heart Failure and Preserved Ejection Fraction:A Specific HFpEF Phenotype", "journal": "Front Cardiovasc Med", "authors": ["Elsanhoury A", "Nelki V", "Kelle S", "Van Linthout S", "Tschöpe C"], "date": "2021-09-17T00:00:00Z", "doi": "10.3389/fcvm.2021.720690", "meta_date_publication": "2021", "meta_volume": "8", "meta_issue": "", "meta_pages": "720690", "score": 50273.164, "text_hl": "A recent meta-analysis by Halabi et al. concluded that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment is associated with a reduction in mortality in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Heart_Failure_Diastolic</m> @DISEASE_MESH:D054144 @@@HFpEF@@@. ", "citations": {"NLM": "Elsanhoury A, Nelki V, Kelle S, Van Linthout S, Tschöpe C. Epicardial Fat Expansion in Diabetic and Obese Patients With Heart Failure and Preserved Ejection Fraction:A Specific HFpEF Phenotype Front Cardiovasc Med. 2021;8():720690. PMID: 34604353", "BibTeX": "@article{34604353, title={Epicardial Fat Expansion in Diabetic and Obese Patients With Heart Failure and Preserved Ejection Fraction:A Specific HFpEF Phenotype}, author={Elsanhoury A and Nelki V and Kelle S and Van Linthout S and Tschöpe C}, journal={Front Cardiovasc Med}, volume={8}, pages={720690}}"}}, {"_id": "34079271", "pmid": 34079271, "pmcid": "PMC8164213", "title": "Epigenetic Therapies for Heart Failure: Current Insights and Future Potential", "journal": "Vasc Health Risk Manag", "authors": ["Napoli C", "Bontempo P", "Palmieri V", "Coscioni E", "Maiello C", "Donatelli F", "Benincasa G"], "date": "2021-05-24T00:00:00Z", "doi": "10.2147/VHRM.S287082", "meta_date_publication": "2021", "meta_volume": "17", "meta_issue": "", "meta_pages": "247-254", "score": 50267.617, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has been associated with a reduced mortality in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Heart_Failure_Diastolic</m> @DISEASE_MESH:D054144 @@@HFpEF@@@, even if female gender was associated with worse outcomes. ", "citations": {"NLM": "Napoli C, Bontempo P, Palmieri V, Coscioni E, Maiello C, Donatelli F, Benincasa G. Epigenetic Therapies for Heart Failure: Current Insights and Future Potential Vasc Health Risk Manag. 2021;17():247-254. PMID: 34079271", "BibTeX": "@article{34079271, title={Epigenetic Therapies for Heart Failure: Current Insights and Future Potential}, author={Napoli C and Bontempo P and Palmieri V and Coscioni E and Maiello C and Donatelli F and Benincasa G}, journal={Vasc Health Risk Manag}, volume={17}, pages={247-254}}"}}, {"_id": "32758236", "pmid": 32758236, "pmcid": "PMC7409497", "title": "Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysis", "journal": "Cardiovasc Diabetol", "authors": ["Halabi A", "Sen J", "Huynh Q", "Marwick TH"], "date": "2020-08-05T00:00:00Z", "doi": "10.1186/s12933-020-01100-w", "meta_date_publication": "2020 Aug 5", "meta_volume": "19", "meta_issue": "1", "meta_pages": "124", "score": 50263.812, "text_hl": "However, the benefit of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Heart_Failure_Diastolic</m> @DISEASE_MESH:D054144 @@@HF with preserved ejection@@@ fraction (HFpEF) has yet to be explored. ", "citations": {"NLM": "Halabi A, Sen J, Huynh Q, Marwick TH. Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysis Cardiovasc Diabetol. 2020 Aug 5;19(1):124. PMID: 32758236", "BibTeX": "@article{32758236, title={Metformin treatment in heart failure with preserved ejection fraction: a systematic review and meta-regression analysis}, author={Halabi A and Sen J and Huynh Q and Marwick TH}, journal={Cardiovasc Diabetol}, volume={19}, number={1}, pages={124}}"}}, {"_id": "37383601", "pmid": 37383601, "pmcid": "PMC10294070", "title": "Targeting epicardial adipose tissue: A potential therapeutic strategy for heart failure with preserved ejection fraction with type 2 diabetes mellitus", "journal": "World J Diabetes", "authors": ["Shi YJ", "Dong GJ", "Guo M"], "date": "2023-06-15T00:00:00Z", "doi": "10.4239/wjd.v14.i6.724", "meta_date_publication": "2023 Jun 15", "meta_volume": "14", "meta_issue": "6", "meta_pages": "724-740", "score": 50255.254, "text_hl": "...@<m>DISEASE_Heart_Failure_Diastolic</m> @DISEASE_MESH:D054144 @@@Heart failure with preserved ejection fraction@@@ (@<m>DISEASE_Heart_Failure_Diastolic</m> @DISEASE_MESH:D054144 @@@HFpEF@@@) is a heterogeneous syndrome with various comorbidities, multiple cardiac and extracardiac pathophysiologic abnormalities, and diverse phenotypic presentations. ", "citations": {"NLM": "Shi YJ, Dong GJ, Guo M. Targeting epicardial adipose tissue: A potential therapeutic strategy for heart failure with preserved ejection fraction with type 2 diabetes mellitus World J Diabetes. 2023 Jun 15;14(6):724-740. PMID: 37383601", "BibTeX": "@article{37383601, title={Targeting epicardial adipose tissue: A potential therapeutic strategy for heart failure with preserved ejection fraction with type 2 diabetes mellitus}, author={Shi YJ and Dong GJ and Guo M}, journal={World J Diabetes}, volume={14}, number={6}, pages={724-740}}"}}, {"_id": "30567709", "pmid": 30567709, "pmcid": "PMC6314384", "title": "Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance", "journal": "J Gen Physiol", "authors": ["Slater RE", "Strom JG", "Methawasin M", "Liss M", "Gotthardt M", "Sweitzer N", "Granzier HL"], "date": "2019-01-07T00:00:00Z", "doi": "10.1085/jgp.201812259", "meta_date_publication": "2019 Jan 7", "meta_volume": "151", "meta_issue": "1", "meta_pages": "42-52", "score": 50069.797, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ improves diastolic function in an @<m>DISEASE_Heart_Failure_Diastolic</m> @DISEASE_MESH:D054144 @@@HFpEF@@@-like @SPECIES_10090 @@@mouse@@@ model by increasing @GENE_TTN @GENE_22138 @@@titin@@@ compliance", "citations": {"NLM": "Slater RE, Strom JG, Methawasin M, Liss M, Gotthardt M, Sweitzer N, Granzier HL. Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance J Gen Physiol. 2019 Jan 7;151(1):42-52. PMID: 30567709", "BibTeX": "@article{30567709, title={Metformin improves diastolic function in an HFpEF-like mouse model by increasing titin compliance}, author={Slater RE and Strom JG and Methawasin M and Liss M and Gotthardt M and Sweitzer N and Granzier HL}, journal={J Gen Physiol}, volume={151}, number={1}, pages={42-52}}"}}]}